HALO · NASDAQ · Healthcare · Biotechnology

Halozyme Therapeutics

—近一月
價格暫不可用
  • 52週區間61.23–116.85
  • 本益比32.50
  • 市值124.68億

最新消息

載入中...

簡介

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables ...

halozyme.com